Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Aravindhan Veerapandiyan

Concepts (215)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Muscular Dystrophy, Duchenne
7
2024
23
3.290
 Why?
Muscular Atrophy, Spinal
5
2024
13
3.100
 Why?
Oligonucleotides
4
2020
81
2.110
 Why?
Genetic Therapy
5
2024
117
1.690
 Why?
Pneumonia, Viral
3
2020
170
1.680
 Why?
Coronavirus Infections
3
2020
179
1.650
 Why?
Spastic Paraplegia, Hereditary
2
2022
2
1.620
 Why?
Mutation
12
2023
1288
1.530
 Why?
Disease Management
2
2020
175
1.250
 Why?
Dystonic Disorders
2
2023
6
1.230
 Why?
Pandemics
4
2022
567
1.150
 Why?
Humans
48
2024
50201
0.990
 Why?
Spasms, Infantile
2
2018
28
0.980
 Why?
Child
23
2024
6862
0.970
 Why?
Epilepsy
2
2022
176
0.960
 Why?
Neuromuscular Diseases
1
2024
30
0.910
 Why?
Spinal Muscular Atrophies of Childhood
2
2020
9
0.890
 Why?
Recombinant Fusion Proteins
2
2024
183
0.880
 Why?
Peroneal Neuropathies
2
2021
5
0.880
 Why?
Intellectual Disability
2
2022
128
0.870
 Why?
Dystonia
1
2023
10
0.860
 Why?
Dystrophin
4
2024
7
0.850
 Why?
Nerve Tissue Proteins
2
2021
191
0.800
 Why?
Myasthenic Syndromes, Congenital
1
2021
7
0.770
 Why?
Chromosomes, Human, Pair 22
2
2011
39
0.740
 Why?
Fasciculation
1
2020
2
0.730
 Why?
Isaacs Syndrome
1
2020
2
0.730
 Why?
Hereditary Sensory and Motor Neuropathy
1
2020
3
0.720
 Why?
Seizures
3
2018
195
0.720
 Why?
Muscular Dystrophies
1
2020
15
0.710
 Why?
Male
28
2024
25572
0.710
 Why?
Myopathies, Structural, Congenital
1
2020
10
0.710
 Why?
Codon, Nonsense
1
2020
26
0.700
 Why?
Adolescent
16
2024
6459
0.700
 Why?
Anticonvulsants
2
2012
125
0.700
 Why?
Apoptosis Regulatory Proteins
1
2020
85
0.690
 Why?
Charcot-Marie-Tooth Disease
1
2019
8
0.680
 Why?
Phenotype
3
2020
732
0.680
 Why?
Glucocorticoids
3
2020
230
0.680
 Why?
Epstein-Barr Virus Infections
1
2020
29
0.670
 Why?
Encephalitis
2
2017
40
0.650
 Why?
Adaptor Proteins, Signal Transducing
1
2020
197
0.650
 Why?
Multiple Sclerosis
1
2019
63
0.650
 Why?
Consensus
1
2020
158
0.650
 Why?
Infant
9
2020
3584
0.640
 Why?
Chromosome Duplication
1
2018
7
0.630
 Why?
Survival of Motor Neuron 1 Protein
1
2018
3
0.620
 Why?
Munc18 Proteins
1
2018
3
0.620
 Why?
Child, Preschool
13
2024
3896
0.620
 Why?
Spinal Puncture
1
2018
16
0.610
 Why?
Microfilament Proteins
1
2018
42
0.610
 Why?
Electroencephalography
6
2018
303
0.610
 Why?
Epilepsies, Myoclonic
1
2018
12
0.600
 Why?
Head
1
2018
70
0.600
 Why?
Chromosomes, Human, Pair 1
1
2018
92
0.590
 Why?
Chromosome Deletion
3
2018
140
0.570
 Why?
Delivery of Health Care
1
2020
308
0.570
 Why?
Central Nervous System Diseases
1
2017
26
0.570
 Why?
Pedigree
3
2022
125
0.560
 Why?
Attention Deficit Disorder with Hyperactivity
1
2018
173
0.540
 Why?
Carrier Proteins
1
2018
302
0.540
 Why?
Muscular Diseases
2
2020
61
0.520
 Why?
Female
20
2024
26829
0.480
 Why?
DiGeorge Syndrome
2
2012
17
0.470
 Why?
Emergency Service, Hospital
1
2018
482
0.460
 Why?
Tomography, X-Ray Computed
1
2018
1160
0.410
 Why?
Brain
2
2018
1311
0.410
 Why?
Epilepsy, Complex Partial
1
2012
3
0.400
 Why?
Carbamazepine
1
2012
13
0.400
 Why?
Epilepsy, Tonic-Clonic
1
2011
3
0.370
 Why?
Pyridoxal Phosphate
1
2011
10
0.370
 Why?
Cephalometry
1
2011
19
0.370
 Why?
Myoglobinuria
1
2010
2
0.370
 Why?
Triazines
1
2011
24
0.370
 Why?
Epilepsy, Absence
1
2011
11
0.370
 Why?
Ocular Motility Disorders
1
2011
17
0.370
 Why?
BRCA2 Protein
1
2010
16
0.360
 Why?
Velopharyngeal Insufficiency
1
2011
17
0.360
 Why?
Pseudolymphoma
1
2010
4
0.360
 Why?
Retrospective Studies
7
2021
6190
0.360
 Why?
Prednisolone
3
2020
55
0.350
 Why?
Mutation, Missense
1
2010
104
0.350
 Why?
Treatment Outcome
5
2024
5203
0.340
 Why?
Drug Overdose
1
2011
159
0.320
 Why?
Young Adult
8
2024
4052
0.300
 Why?
Diagnosis, Differential
3
2020
1041
0.290
 Why?
Follow-Up Studies
3
2021
2188
0.250
 Why?
Drug Therapy, Combination
2
2020
382
0.250
 Why?
Muscle, Skeletal
1
2010
781
0.240
 Why?
Heterozygote
2
2023
82
0.240
 Why?
Genetic Vectors
1
2024
126
0.230
 Why?
Dependovirus
1
2024
103
0.220
 Why?
Histone-Lysine N-Methyltransferase
1
2023
57
0.210
 Why?
Magnetic Resonance Imaging
3
2018
1529
0.200
 Why?
Adenosine Triphosphatases
1
2022
87
0.200
 Why?
Adult
8
2024
13486
0.200
 Why?
Semaphorins
1
2021
3
0.200
 Why?
Atrophy
1
2022
38
0.200
 Why?
Patient Care Planning
1
2022
67
0.190
 Why?
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
2021
4
0.190
 Why?
Cell Adhesion Molecules
1
2021
87
0.190
 Why?
Cohort Studies
2
2018
1414
0.180
 Why?
Receptors, Cell Surface
1
2021
120
0.180
 Why?
Introns
2
2018
49
0.180
 Why?
Muscle Cramp
1
2020
5
0.180
 Why?
Recovery of Function
1
2021
188
0.170
 Why?
Health Services Accessibility
1
2024
420
0.170
 Why?
Flavoproteins
1
2019
5
0.170
 Why?
Injections, Spinal
1
2019
19
0.170
 Why?
Phosphoric Monoester Hydrolases
1
2019
21
0.170
 Why?
Palliative Care
1
2022
188
0.170
 Why?
Physical Endurance
1
2019
30
0.170
 Why?
Hand Strength
1
2019
22
0.170
 Why?
Facial Paralysis
1
2020
23
0.170
 Why?
Muscle Weakness
1
2020
45
0.170
 Why?
Membrane Proteins
1
2022
347
0.170
 Why?
Neurologic Examination
1
2019
76
0.170
 Why?
Steroids
1
2019
56
0.170
 Why?
Age of Onset
1
2019
108
0.170
 Why?
Abnormalities, Multiple
2
2011
167
0.160
 Why?
Age Factors
3
2018
1096
0.160
 Why?
Scoliosis
1
2019
60
0.160
 Why?
Aminomethyltransferase
1
2018
1
0.160
 Why?
Spinal Fusion
1
2019
69
0.160
 Why?
Hyperglycinemia, Nonketotic
1
2018
5
0.160
 Why?
Hyperammonemia
1
2018
23
0.160
 Why?
Activities of Daily Living
1
2019
174
0.160
 Why?
Lumbosacral Region
1
2018
12
0.160
 Why?
X-Rays
1
2018
55
0.150
 Why?
Anti-Inflammatory Agents
1
2019
162
0.150
 Why?
Neuraminidase
1
2018
3
0.150
 Why?
Mucolipidoses
1
2018
4
0.150
 Why?
Pons
1
2017
33
0.140
 Why?
Methylprednisolone
1
2017
38
0.140
 Why?
Brain Stem
1
2017
56
0.140
 Why?
Prevalence
1
2020
960
0.140
 Why?
Disease Progression
1
2019
821
0.140
 Why?
Cross-Sectional Studies
2
2019
1580
0.130
 Why?
Quality of Life
1
2022
843
0.130
 Why?
Middle Aged
4
2024
12356
0.130
 Why?
T-Lymphocytes
1
2017
329
0.120
 Why?
RNA, Messenger
1
2018
1097
0.120
 Why?
Aged
3
2021
9505
0.120
 Why?
Chronic Disease
1
2017
568
0.120
 Why?
Antibodies
2
2012
151
0.120
 Why?
Kv1.1 Potassium Channel
1
2013
2
0.110
 Why?
Caregivers
2
2024
213
0.100
 Why?
Dipeptides
1
2012
22
0.100
 Why?
Aspartic Acid
1
2012
49
0.100
 Why?
Folic Acid Deficiency
1
2012
43
0.100
 Why?
Folate Receptor 1
1
2012
25
0.100
 Why?
Ear
1
2011
17
0.100
 Why?
Prefrontal Cortex
1
2012
82
0.100
 Why?
Hypoparathyroidism
1
2011
5
0.100
 Why?
Immune System Diseases
1
2011
8
0.100
 Why?
Facies
1
2011
35
0.100
 Why?
Eye Abnormalities
1
2011
24
0.100
 Why?
Nose
1
2011
31
0.090
 Why?
Epilepsies, Partial
1
2011
12
0.090
 Why?
Platybasia
1
2011
5
0.090
 Why?
Frontal Lobe
1
2011
47
0.090
 Why?
Infant, Newborn
1
2018
2770
0.090
 Why?
Receptors, N-Methyl-D-Aspartate
1
2011
127
0.090
 Why?
Glycogen Storage Disease Type III
1
2010
1
0.090
 Why?
Glycogen Debranching Enzyme System
1
2010
2
0.090
 Why?
Cervical Vertebrae
1
2011
58
0.090
 Why?
Genetic Heterogeneity
1
2010
18
0.090
 Why?
Genetic Predisposition to Disease
1
2013
508
0.090
 Why?
Mental Disorders
2
2024
400
0.090
 Why?
Cognition Disorders
1
2011
199
0.090
 Why?
Syndrome
1
2010
239
0.090
 Why?
Cleft Palate
1
2011
76
0.080
 Why?
Brain Mapping
1
2011
227
0.080
 Why?
United States
1
2020
4898
0.080
 Why?
Lymph Nodes
1
2010
258
0.080
 Why?
Myocardium
1
2010
443
0.070
 Why?
Dose-Response Relationship, Drug
1
2011
1356
0.070
 Why?
Skin
1
2010
416
0.070
 Why?
Exercise
1
2010
504
0.070
 Why?
Heart Defects, Congenital
1
2011
590
0.060
 Why?
Delphi Technique
1
2024
54
0.060
 Why?
Myocarditis
1
2024
45
0.050
 Why?
Azo Compounds
1
2022
10
0.050
 Why?
Pilot Projects
1
2024
703
0.050
 Why?
Health Personnel
1
2024
250
0.050
 Why?
Electrodiagnosis
1
2021
12
0.050
 Why?
Genetic Association Studies
1
2021
115
0.050
 Why?
Pyrimidines
1
2022
192
0.050
 Why?
Homozygote
1
2018
57
0.040
 Why?
Prospective Studies
1
2024
2396
0.040
 Why?
Signal Transduction
1
2021
1612
0.030
 Why?
Flurothyl
1
2013
1
0.030
 Why?
Kindling, Neurologic
1
2013
3
0.030
 Why?
Aged, 80 and over
1
2021
3158
0.030
 Why?
Mice, Mutant Strains
1
2013
71
0.030
 Why?
Animals, Newborn
1
2013
367
0.030
 Why?
Protons
1
2012
67
0.020
 Why?
Hippocampus
1
2013
220
0.020
 Why?
Chi-Square Distribution
1
2012
280
0.020
 Why?
Magnetic Resonance Spectroscopy
1
2012
246
0.020
 Why?
Autoantibodies
1
2011
114
0.020
 Why?
Anisotropy
1
2011
64
0.020
 Why?
Drug Resistance
1
2011
64
0.020
 Why?
Video Recording
1
2011
79
0.020
 Why?
Neuropsychological Tests
1
2012
337
0.020
 Why?
Diffusion Magnetic Resonance Imaging
1
2011
125
0.020
 Why?
Sequence Homology, Amino Acid
1
2010
145
0.020
 Why?
Exons
1
2010
95
0.020
 Why?
Amino Acid Sequence
1
2010
576
0.020
 Why?
Molecular Sequence Data
1
2010
795
0.020
 Why?
Disease Models, Animal
1
2013
1419
0.020
 Why?
Mice, Inbred C57BL
1
2013
1782
0.020
 Why?
Case-Control Studies
1
2011
1145
0.020
 Why?
Mice
1
2013
5673
0.010
 Why?
Animals
1
2013
13141
0.010
 Why?
Veerapandiyan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (215) concept(s)
_
Co-Authors Expand Description
See all (24) people
_
Similar People Expand Description
See all (31) people
_
Same Department Expand Description
Search Department